This compound is primarily utilized in pharmaceutical research and development due to its structural properties, which make it a valuable intermediate in the synthesis of various biologically active molecules. Its trifluoromethyl group enhances the metabolic stability and bioavailability of potential drug candidates, making it particularly useful in the design of central nervous system (CNS) targeting agents. Researchers often employ it in the creation of compounds aimed at treating neurological disorders, such as depression, anxiety, and neurodegenerative diseases. Additionally, its unique structure allows for exploration in medicinal chemistry for the development of novel therapeutic agents with improved efficacy and reduced side effects.